Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Both SIADH and CSW present with hyponatraemia and high urine sodium. π Key difference = **Volume status**: - CSW β Hypovolaemic π§ - SIADH β Euvolaemic/Hypervolaemic βοΈ
| Feature | CSW | SIADH |
|---|---|---|
| Volume Status | Hypovolaemic π§ (dehydrated) | Euvolaemic / Hypervolaemic βοΈ |
| Urine Sodium | High (>40 mmol/L, often very high) | High (>20 mmol/L but not extreme) |
| Urine Output | Polyuria (often >2.5 L/day) | Normal or low |
| Main Mechanism | Renal salt wasting due to CNS natriuretic peptides | Excess ADH secretion β water retention |
| Management | Replace fluids + sodium (0.9% saline or hypertonic 3% NaCl) + fludrocortisone if refractory | Fluid restriction Β± demeclocycline / vasopressin antagonists |
Cerebral salt wasting is characterised by renal loss of sodium + water β hypovolaemic hyponatraemia. - Occurs after CNS insults (SAH, TBI, neurosurgery, infections). - Key distinction from SIADH: both cause hyponatraemia with high urine sodium, but - CSW = hypovolaemia (low BP, tachycardia, dehydration). - SIADH = euvolaemia/hypervolaemia. - Management: Sodium + volume replacement, fludrocortisone in resistant cases. Fluid restriction is contraindicated (unlike SIADH).